Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2002 1
2003 1
2005 1
2006 1
2009 1
2014 1
2015 3
2016 1
2018 1
2020 4
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.
Fritz D, van de Beek D, Brouwer MC. Fritz D, et al. BMC Neurol. 2016 Nov 15;16(1):220. doi: 10.1186/s12883-016-0741-x. BMC Neurol. 2016. PMID: 27846819 Free PMC article. Review.
Pleiocytosis and elevated CSF protein were found in 58 and 63%. MRI of the brain showed abnormalities in 70%. Chest X-ray, chest CT, or gallium-67-scintigraphy showed findings consistent with sarcoidosis in 60%, 70% and 69%, respectively. ...
Pleiocytosis and elevated CSF protein were found in 58 and 63%. MRI of the brain showed abnormalities in 70%. Chest X-ray …
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.
Guinto E, Gerayeli FV, Eddy RL, Lee H, Milne S, Sin DD. Guinto E, et al. Eur Respir Rev. 2023 Aug 9;32(169):220253. doi: 10.1183/16000617.0253-2022. Print 2023 Sep 30. Eur Respir Rev. 2023. PMID: 37558261 Free PMC article. Review.
We performed a systematic review and meta-analysis to determine relationships between dyspnoea and imaging abnormalities over time in post-COVID-19 patients. METHODS: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we analy …
We performed a systematic review and meta-analysis to determine relationships between dyspnoea and imaging abnormalities over time in …
Corticosteroids for pulmonary sarcoidosis.
Paramothayan NS, Lasserson TJ, Jones PW. Paramothayan NS, et al. Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD001114. doi: 10.1002/14651858.CD001114.pub2. Cochrane Database Syst Rev. 2005. PMID: 15846612 Free PMC article. Review.
DATA COLLECTION AND ANALYSIS: Study quality was assessed and data extracted independently by two reviewers. The primary outcome was CXR (chest x-ray). Outcomes were analysed as continuous and dichotomous outcomes, using standard statistical techniques. ...In …
DATA COLLECTION AND ANALYSIS: Study quality was assessed and data extracted independently by two reviewers. The primary outcome was CXR ( …
Methodological and Clinimetric Evaluation of Inspiratory Respiratory Muscle Ultrasound in the Critical Care Setting: A Systematic Review and Meta-Analysis.
Truong D, Abo S, Whish-Wilson GA, D'Souza AN, Beach LJ, Mathur S, Mayer KP, Ntoumenopoulos G, Baldwin C, El-Ansary D, Paris MT, Mourtzakis M, Morris PE, Pastva AM, Granger CL, Parry SM, Sarwal A. Truong D, et al. Crit Care Med. 2023 Feb 1;51(2):e24-e36. doi: 10.1097/CCM.0000000000005739. Epub 2023 Jan 20. Crit Care Med. 2023. PMID: 36661463
Pooled data demonstrated acceptable to excellent accuracy for DT, DTF, and DE to predicting weaning outcome after 48 to 72 hours postextubation (DTF AUC, 0.79; 95% CI, 0.73-0.85). DT imaging was responsive to change over time. Only three eligible studies were available for …
Pooled data demonstrated acceptable to excellent accuracy for DT, DTF, and DE to predicting weaning outcome after 48 to 72 hours postextubat …
Corticosteroids for pulmonary sarcoidosis.
Paramothayan NS, Jones PW. Paramothayan NS, et al. Cochrane Database Syst Rev. 2000;(4):CD001114. doi: 10.1002/14651858.CD001114. Cochrane Database Syst Rev. 2000. PMID: 11034698 Updated. Review.
The inhaled steroid was budesonide 0.8 - 1.2 mg/day. Outcomes were symptoms, chest X-ray (CXR) changes, lung function and global scores (a combination of all three outcomes). ...In another, symptoms improved at the end of six months of treatment. REVIEWER'S C …
The inhaled steroid was budesonide 0.8 - 1.2 mg/day. Outcomes were symptoms, chest X-ray (CXR) changes, lung function a …
Corticosteroids for pulmonary sarcoidosis.
Paramothayan NS, Jones PW. Paramothayan NS, et al. Cochrane Database Syst Rev. 2000;(2):CD001114. doi: 10.1002/14651858.CD001114. Cochrane Database Syst Rev. 2000. PMID: 10796598 Updated. Review.
The inhaled steroid was budesonide 0.8 - 1.2 mg/day. Outcomes were symptoms, chest X-ray (CXR) changes, lung function and global scores (a combination of all three outcomes). ...In another, symptoms improved at the end of six months of treatment. REVIEWER'S C …
The inhaled steroid was budesonide 0.8 - 1.2 mg/day. Outcomes were symptoms, chest X-ray (CXR) changes, lung function a …
Corticosteroid therapy in pulmonary sarcoidosis: a systematic review.
Paramothayan S, Jones PW. Paramothayan S, et al. JAMA. 2002 Mar 13;287(10):1301-7. doi: 10.1001/jama.287.10.1301. JAMA. 2002. PMID: 11886322 Review.
OBJECTIVE: To assess the effect of oral and inhaled corticosteroids on chest radiograph results, symptoms, pulmonary function, and long-term outcome in pulmonary sarcoidosis. ...In 2 small studies of inhaled corticosteroids, there was no effect on chest radiograph a …
OBJECTIVE: To assess the effect of oral and inhaled corticosteroids on chest radiograph results, symptoms, pulmonary function, and lo …
Asthma-community acquired pneumonia co-diagnosis in children: a scoping review.
Rashid MM, Ahmed S, Owens L, Hu N, Jaffe A, Homaira N. Rashid MM, et al. J Asthma. 2024 Apr;61(4):282-291. doi: 10.1080/02770903.2023.2280843. Epub 2023 Nov 23. J Asthma. 2024. PMID: 37943507 Review.
Separate guidelines including Modified Global Initiative for Asthma (GINA) guidelines; modified Integrated Management of Childhood Illness (IMCI) guidelines; and a consensus guideline developed by the Pediatric Infectious Diseases Society (PIDS) and Infectious Diseases Society of …
Separate guidelines including Modified Global Initiative for Asthma (GINA) guidelines; modified Integrated Management of Childhood Illness ( …
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Paramothayan S, Lasserson TJ, Walters EH. Paramothayan S, et al. Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD003536. doi: 10.1002/14651858.CD003536.pub2. Cochrane Database Syst Rev. 2006. PMID: 16856012 Free PMC article. Review.
No data could be combined for a meta-analysis. Data on lung function, chest x-ray scores and dyspnoea were largely inconclusive. Adverse effects were associated with methotrexate, cyclosporin A, chloroquine and pentoxifylline. ...
No data could be combined for a meta-analysis. Data on lung function, chest x-ray scores and dyspnoea were largely inco …
Pediatric lung imaging features of COVID-19: A systematic review and meta-analysis.
Nino G, Zember J, Sanchez-Jacob R, Gutierrez MJ, Sharma K, Linguraru MG. Nino G, et al. Pediatr Pulmonol. 2021 Jan;56(1):252-263. doi: 10.1002/ppul.25070. Epub 2020 Nov 2. Pediatr Pulmonol. 2021. PMID: 32926572 Free PMC article.
RESULTS: A total of 29 articles (n = 1026 children) based on chest computerized tomography (CT) images were included. The main results of this comprehensive analysis are as follows: (1) Over a third of pediatric patients with COVID-19 (35.7%, 95% CI: 27.5%-44%) had normal …
RESULTS: A total of 29 articles (n = 1026 children) based on chest computerized tomography (CT) images were included. The main result …
22 results